Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-03-19 to 2024-04-03
Current total value of award: $5374
Description: 8510512446!ANTIDOTE TREATMENT